期刊文献+

胃癌组织及转移组织中DNA甲基化差异的研究 被引量:1

Difference in methylation of genomic DNA between gastric primary cancer and lymph nodes with metastatic gastric cancer
原文传递
导出
摘要 目的研究胃癌原发灶和转移淋巴结组织间基因组DNA甲基化程度的差异以及寻找胃癌淋巴转移抑制基因。方法应用甲基化CpG岛扩增(MCA)方法富集甲基化的基因组DNA序列,以转移淋巴结MCA产物为检测子,原发灶MCA产物为驱赶子,进行代表性差异显示分析(RDA)。将获得的甲基化差异片段克隆、测序,获得碱基序列,用生物信息学进行分析。结果获得19个差异序列,分布于5′端,外显子,内含子及3′端。其中KL59位于9p21,为p16基因的第一外显子内;KL22位于PTPRG基因启动子区。以KL22作探针与驱赶子、检测子及3轮RDA产物杂交,除驱赶子外都有杂交信号。结论胃癌原发灶与转移淋巴结组织间DNA甲基化存在差异,MCA-RDA方法为一种较好的分析方法。 Objective To investigate the difference in methylation of genomic DNA between gastric primary cancer and lymph nodes with metastatic gastric cancer. Methods Methylation CpG island amplification (MCA) was used to enrich the methylated DNA sequences in the cancer tissues and lymph nodes with metastatic gastric cancer resected during operation from 5 patients. Representational difference analysis (RDA) was conducted with the MCA products from the lymph nodes with metastatic gastric cancer as testers and the MCA products of the gastric primary cancer as drivers. The differentially methylated DNA fragments were cloned and sequenced, and underwent similarity analysis by BLAST system. The relationship between the clone sequence and related gene was analyzed by GenBank. Hybridization analysis was performed, using the No 1 ~ 3 round RDA products and the MCA products of the tissues of gastric primary cancer and lymph nodes with metastatic gastric cancer with digoxin-labeled KL22 fragment as probe. Results Nineteen differentially methylated DNA sequences were obtained, distributed at the 5'-end, exon, intron, and 3'-end. KL59 fragment was located in the 9q21, the first exon of p16 gene. KL12 fragment was located in the promoter region of phophotyrosine phophatase receptor G (PTPRG) gene. Hybridization signals were obtained for all No 1 ~ 3 round RDA products and all testers, but not for the drivers. Conclusion There is a difference in DNA methylation between the tissues of primary cancer and lymph nodes with metastatic gastric cancer. MCA-RNA is an effective method to study the gene methylation. PTPRG gene may be a candidate gene for metastasis of gastric cancer.
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第8期536-539,共4页 National Medical Journal of China
基金 国家自然科学基金资助项目(30271477)
关键词 胃肿瘤 淋巴转移 DNA甲基化 基因 抑制 肿瘤 Stomach neoplasms Lymphatic metastasis DNA methylation Genes,suppressor
  • 相关文献

参考文献9

  • 1Toyota M,Itoth F,Imai K.DNA methylation and gastrointestinal malignancies:functional consequences and clinical and implications.J Gastroenterol,2000,35:727-734.
  • 2Rashid A,Shen LL,Morris JS.et al.CpG island methylation in colorectal adenomas.American J Patbology,2001,159:1129-1135.
  • 3Toyota M,Ho C,Ahujia N,et al.Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.Cancer Res,1999,59:2307-2312.
  • 4Lisitsyn NI,Lisitsyn NA,Wigler M.Cloning the differences between two complex genomes.Science,1993,259:946-951.
  • 5Catteau A,Harris WH,Xu CF.et al.Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer.Oncogen,1999,18:1957-1965.
  • 6Gonzalgo ML,Bender CM,You EH,et al.Low Frequency of p16/CDKN2A Methylation Analysis of Primary Tumors.Cancer Res,1997,57:5336-5347.
  • 7邓大君,邓国仁,吕有勇,周静,辛慧君.变性高效液相色谱法检测CpG岛胞嘧啶甲基化[J].中华医学杂志,2001,81(3):158-161. 被引量:31
  • 8Wang Z,Shen D,Parsons DW,et al.Mutational analysis of the tyrosine phosphatome in colorectal cancers.Science,2004,304:1164-1166.
  • 9Esteller M,Hamilton SR,Burger PC,et al.Inactivation of the DNA repair gene O6-methylguanine-DNA methylatransferase by promoter hypermethylation is a common event in primary human neoplasia.Cancer Res,1999,59:739-797.

二级参考文献5

  • 1萨姆布鲁克J 弗里奇EF.分子克隆实验指南(第2版)[M].北京:科学出版社,1992.463-468.
  • 2Shen P,Proc Nat Acad Sci USA,2000年,97卷,7354页
  • 3Deng G,Cancer Res,1999年,59卷,2029页
  • 4金冬雁(译),分子克隆实验指南(第2版),1992年,954页
  • 5Wang R Y H,Nucl Acids Res,1980年,8卷,4777页

共引文献30

同被引文献6

  • 1Manel E, Stanley RH, Peter C, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltrnasferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res, 1999, 59:793-797.
  • 2Pogribny IP, James SJ. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation. Cancer Lett, 2002, 176 : 169-174.
  • 3Motiwala T, Ghoshal K, Das A, et al. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene, 2003, 22: 6319-6331.
  • 4Wang Z, Shen D, Parsons DW, et al. Mutational analysis of the tyrosln phophatome in colorectal cancers. Science, 2004, 304: 1164-1166.
  • 5LaForgia S, Morse B, Levy J, et al. Receptor protein-tyrosine phophatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci USA, 1991, 88: 5036-5040.
  • 6van Doom R, Zoutman WH, Dijkman R, et al. Epigenetic profiling of cutaneous T-cell lymphoma: Promoter hypermethylation of multiple tumor suppressor genes including BCL7a, ptprg, and p73. J Clin Oncol, 2005, 23:3886-3896.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部